ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,750 | 0.0% | 89,456 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $2,750 | -20.3% | 89,456 | -6.6% | 0.01% | -35.3% |
| Q1 2023 | $3,450 | +170.8% | 95,769 | +202.1% | 0.02% | +142.9% |
| Q4 2022 | $1,274 | -99.9% | 31,697 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $1,274,000 | -1.5% | 31,697 | +3.0% | 0.01% | 0.0% |
| Q2 2022 | $1,294,000 | -28.1% | 30,783 | -33.4% | 0.01% | 0.0% |
| Q1 2022 | $1,800,000 | +44.1% | 46,192 | +47.3% | 0.01% | +75.0% |
| Q4 2021 | $1,249,000 | +19.8% | 31,351 | +8.6% | 0.00% | 0.0% |
| Q3 2021 | $1,043,000 | -57.8% | 28,858 | -52.1% | 0.00% | 0.0% |
| Q2 2021 | $2,470,000 | -10.4% | 60,258 | -4.7% | 0.00% | -33.3% |
| Q1 2021 | $2,756,000 | -94.0% | 63,204 | -62.1% | 0.01% | -70.0% |
| Q4 2020 | $45,906,000 | – | 166,766 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |